Recently, Huapu Scientific Instruments (Beijing) Technology Co., Ltd. (hereinafter referred to as "Huapu Scientific Instruments"), a domestic enterprise with a comprehensive platform covering chromatographic equipment, software and consumables, has completed a Pre-Series B financing round of over 100 million yuan. This round of financing is co-led by the Beijing High-end, Precise and Advanced Industry Fund managed by Beijing Guorui Fund and Beijing Gongtou Investment, with follow-up investments from existing shareholders Honghui Fund and Jiaqiao Capital. The funds raised in this round will be mainly used for Huapu Scientific Instruments to further build its domestic and international sales channels and develop next-generation products.

Since its establishment in 2015, Huapu Scientific Instruments has built a product portfolio covering HPLC (High-Performance Liquid Chromatograph), UHPLC (Ultra-High Performance Liquid Chromatograph), as well as supporting software and corresponding consumables. At present, the company's self-branded instruments have a stock of thousands of units in the mainstream application market of chromatography. Relying on its mature and comprehensive compliant software system and service system, Huapu Scientific Instruments has established significant competitive advantages in the domestic liquid chromatography field. It is one of the few manufacturers in the industry that can enter standard-setting institutions such as customs, quality inspection, and drug supervision, as well as key commercial customers including pharmaceutical enterprises and CRO companies on a large scale.

Based on its existing products, Huapu Scientific Instruments is also continuously expanding its product portfolio to better realize the platform-based scale effect. In January this year, Huapu Scientific Instruments reached a strategic cooperation with Zhongyuan Huiji to jointly promote the localization of clinical liquid chromatography and mass spectrometry technologies; it also carried out in-depth industry-university-research cooperation with the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences and East China University of Science and Technology, jointly exploring new models and paths for collaborative innovation.

In May 2023, Nanjing Borui Jiatai Phase II Equity Investment Partnership (Limited Partnership) participated in Huapu Scientific Instruments' Series A financing. Founded in February 2021, this fund is managed by Borui Yuye (Shanghai) Equity Investment Management Co., Ltd., with a total scale of 150 million yuan. Among them, the industrial fund managed by Nanjing Innovation Investment Group contributed 10 million yuan, accounting for 6.67%. The fund mainly invests in high-quality medical and health industry enterprises with growth potential, covering pharmaceuticals, biotechnology, medical services, medical devices, equipment, diagnostics, animal health, and other medical and health-related fields.

Source: Zhou Xin from the Fund Department Review: Xue Yao Release: You Yi